GROUP ONE TRADING, L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$780,785
+33.8%
37,939
+205.7%
0.00%
+50.0%
Q2 2023$583,612
-3.7%
12,412
-14.1%
0.00%0.0%
Q1 2023$605,944
-21.1%
14,441
-28.3%
0.00%0.0%
Q4 2022$768,101
-8.7%
20,139
-6.2%
0.00%0.0%
Q3 2022$841,000
+74.1%
21,472
+43.5%
0.00%
+100.0%
Q2 2022$483,000
+2918.8%
14,958
+3055.7%
0.00%
Q1 2022$16,000
-84.0%
474
-79.8%
0.00%
Q4 2021$100,000
-75.8%
2,349
-74.9%
0.00%
Q3 2021$414,000
-91.9%
9,349
-89.6%
0.00%
-100.0%
Q2 2021$5,129,000
+1029.7%
90,275
+1388.9%
0.01%
+500.0%
Q1 2021$454,000
-31.8%
6,063
-44.4%
0.00%
-50.0%
Q3 2020$666,000
-40.9%
10,898
-59.8%
0.00%
-60.0%
Q2 2020$1,126,000
+15.1%
27,083
-20.5%
0.01%
-37.5%
Q1 2020$978,000
+92.1%
34,066
+839.2%
0.01%
+100.0%
Q3 2019$509,000
-34.9%
3,627
-55.6%
0.00%
-42.9%
Q4 2018$782,000
+586.0%
8,166
+347.9%
0.01%
+600.0%
Q3 2017$114,000
-80.7%
1,823
-75.4%
0.00%
-83.3%
Q2 2017$590,000
-11.9%
7,412
-21.4%
0.01%
-25.0%
Q1 2017$670,000
+885.3%
9,430
+603.7%
0.01%
+700.0%
Q4 2016$68,000
-60.5%
1,340
-76.5%
0.00%
-50.0%
Q2 2016$172,000
+805.3%
5,700
+850.0%
0.00%
Q1 2016$19,000
-91.0%
600
-88.0%
0.00%
-100.0%
Q3 2015$212,000
+28.5%
5,000
+121.7%
0.00%
+50.0%
Q2 2015$165,0002,2550.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders